Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04838834
What this trial is testing

Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children

Who this might be right for
COVID-19SARS-CoV-2Inflammatory Bowel Diseases
Connecticut Children's Medical Center 472
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Early research (Phase 1)Study completedNCT06291883
What this trial is testing

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

Who this might be right for
Coronavirus Disease 2019Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Sheng-Teng Huang 26
Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Early research (Phase 1)Study completedNCT07235137
What this trial is testing

Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

Who this might be right for
Healthy Participant
Pfizer 12
Not applicableStudy completedNCT05196477
What this trial is testing

Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection

Who this might be right for
COVID-19
R-Pharm 3,087
Not applicableStudy completedNCT05289141
What this trial is testing

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 229
Early research (Phase 1)Ended earlyNCT05092581
What this trial is testing

COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT04547127
What this trial is testing

Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Instituto Grifols, S.A. 200
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Not applicableStudy completedNCT05175690
What this trial is testing

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness

Who this might be right for
COVID19
AudibleHealth AI, Inc. 1,126
Not applicableStudy completedNCT04344977
What this trial is testing

Collection of Anti-SARS-CoV-2 Immune Plasma

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 151
Early research (Phase 1)Study completedNCT05898672
What this trial is testing

Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin

Who this might be right for
PharmacokineticsHealthy Volunteers
Pfizer 12
Testing effectiveness (Phase 2)Ended earlyNCT04264533
What this trial is testing

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

Who this might be right for
Vitamin CPneumonia, ViralPneumonia, Ventilator-Associated
ZhiYong Peng 56
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableUnknownNCT04625257
What this trial is testing

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

Who this might be right for
Coronavirus Infectious Disease 2019 (COVID-19)
University Hospital, Basel, Switzerland 1,600
Next Page